PTPRS has been reported to negatively regulate the RAS pathway in colorectal cancer (CRC) by dephosphorylating Erk, leading to its deactivation and preventing its nuclear translocation [65]. This evidence concerns the gene MAPK1 and colorectal carcinoma.